穿戴式心房顫動檢測設備市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球穿戴式心房顫動檢測設備市場價值為 5.962 億美元，預計到 2034 年將以 17.4% 的複合年成長率成長，達到 30 億美元。 2024 年全球穿戴式心房顫動檢測設備市場價值為 5.962 億美元，預計到 2034 年將以 17.4% 的複合年成長率成長，達到 30 億美元。市場成長主要得益於心房顫動發病率的上升、人們對心血管健康的認知的提高以及對遠端監控技術的需求的增加。隨著全球人口老化，心房顫動的風險上升，進一步推動了持續心律監測的需求。貼片、智慧手錶和小型監視器等穿戴式裝置因將易用性與即時健康追蹤相結合而越來越受歡迎。這些創新旨在透過心電圖 (ECG) 訊號或血流模式監測心律，確保有效檢測心律不整。

微型化和感測器精度的提升使這些設備能夠在不干擾日常生活的情況下提供精準的洞察。此外，機器學習和人工智慧與穿戴式裝置的整合增強了其分析能力，能夠識別傳統方法可能忽略的細微心律不整。隨著預防保健日益受到重視，這些進步正在全球範圍內增強市場需求和應用。

智慧手錶市場憑藉其多功能性和便利性，在2024年實現了3.705億美元的收入。這些設備將先進的心電圖功能與健身追蹤和通訊工具等傳統功能結合，對廣大消費者群體極具吸引力。智慧手錶能夠持續監測心臟，發出健康警報，並無縫融入日常生活，使其成為心房顫動檢測的首選。這些穿戴式裝置內建的增強型感測器和演算法進一步提升了檢測的準確性和可靠性，從而贏得了消費者和臨床醫生的信任。

預計到2034年，光電容積描記法(PPG)市場規模將達20億美元。基於PPG的穿戴式裝置為持續心率監測提供了一種非侵入式、經濟實惠且高效的解決方案。這些設備利用光技術檢測血液容積變化，從而能夠識別心房顫動等潛在心律不整。由於PPG感測器成本較低且更易於整合到消費性電子產品中，它們被廣泛應用於健身追蹤器和生活風格智慧手錶。其易用性和即時警報功能進一步促進了需求的成長和市場的擴張。

2024年，由於數位健康科技的廣泛應用、醫療保健支出的增加以及對預防保健的日益重視，美國穿戴式心房顫動檢測設備市場規模達到2.653億美元。隨著美國人口老化，越來越多的人開始使用穿戴式裝置進行主動心血管監測。強大的數位健康生態系統，包括科技公司與醫療保健提供者之間的合作，進一步加速了該地區產品的採用和創新。

塑造穿戴式心房顫動偵測裝置市場的主要公司包括 CardiacSense、ALIVECOR、Garmin、Google、Circular、三星、Withings、蘋果、QARDIO、飛利浦、iRHYTHM、ATsens 和華為。穿戴式心房顫動檢測領域的公司正在積極利用多種策略來鞏固其市場地位。產品創新仍然是核心，各公司正在投資提高感測器靈敏度並改善即時心電圖 (ECG) 和光電容積描記器 (PPG) 功能。

先進的人工智慧和機器學習模型正在開發中，以提高檢測準確性並提供預測分析。與醫療機構的策略合作夥伴關係有助於將穿戴式裝置整合到遠端患者監控系統中。各公司也專注於小型化和提高用戶舒適度，以推動設備的長期使用。法規核准和臨床驗證仍然是增強信任和市場信譽的首要任務。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 心房顫動發生率不斷上升
    • 技術進步
    • 遠距醫療和遠距監控需求激增
    • 提高對心房顫動的認知
  • 產業陷阱與挑戰
    • 複雜的監管格局
    • 與準確性和可靠性相關的問題
  • 機會
    • 與醫療保健系統的整合
    • 人工智慧和機器學習的出現
• 成長潛力分析
• 監管格局
  • 北美洲
  • 歐洲
• 技術和創新格局
  • 當前的技術趨勢
  • 新興技術
• 定價分析
• 未來市場趨勢
• 差距分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
  • 全球的
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • MEA
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係和合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：依產品類型，2021 - 2034 年

• 主要趨勢
• 智慧手錶
• 補丁監視器
• 手提式心電圖監測儀

第6章：市場估計與預測：按技術，2021 - 2034 年

• 主要趨勢
• 基於光電容積描記法 (PPG)
• 基於心電圖（ECG）

第7章：市場估計與預測：按配銷通路，2021 - 2034 年

• 主要趨勢
• 電子商務
• 實體店面

第8章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• ALIVECOR
• Apple
• ATsens
• CardiacSense
• Circular
• Garmin
• Google
• Huawei
• iRHYTHM
• PHILIPS
• QARDIO
• Samsung
• Withings

The Global Wearable Atrial Fibrillation Detection Devices Market was valued at USD 596.2 million in 2024 and is estimated to grow at a CAGR of 17.4% to reach USD 3 billion by 2034. The Global Wearable Atrial Fibrillation Detection Devices Market was valued at USD 596.2 million in 2024 and is estimated to grow at a CAGR of 17.4% to reach USD 3 billion by 2034. The market growth is primarily fueled by the escalating incidence of atrial fibrillation, broader awareness about cardiovascular health, and increasing demand for remote monitoring technologies. As populations continue to age worldwide, the risk of atrial fibrillation rises, further driving the need for continuous heart rhythm monitoring. Wearable devices-such as patches, smartwatches, and compact monitors-are becoming popular as they combine ease of use with real-time health tracking. These innovations are designed to monitor heart rhythm through electrocardiogram (ECG) signals or blood flow patterns, ensuring efficient detection of irregular heartbeats.

Improvements in miniaturization and sensor precision have enabled these devices to deliver accurate insights without disrupting daily routines. Additionally, the integration of machine learning and artificial intelligence into wearables enhances their analytical capabilities, allowing the identification of subtle rhythm irregularities that may go unnoticed using traditional methods. With a rising focus on preventive care, these advancements are reinforcing market demand and adoption at a global scale.

The smartwatches segment generated USD 370.5 million in 2024, due to their multifunctionality and convenience. These devices integrate advanced ECG features alongside traditional capabilities such as fitness tracking and communication tools, which make them highly appealing to a broad consumer base. The ability to perform continuous cardiac monitoring, deliver health alerts, and fit seamlessly into daily life has made smartwatches a preferred option for atrial fibrillation detection. Enhanced sensors and algorithms embedded in these wearables further elevate detection accuracy and reliability, driving consumer and clinical trust.

The photoplethysmography (PPG) segment is forecast to reach USD 2 billion by 2034. PPG-based wearables offer a non-invasive, affordable, and efficient solution for continuous heart rate monitoring. These devices use light-based technology to detect changes in blood volume, enabling the identification of potential arrhythmias like atrial fibrillation. Because PPG sensors are less costly and easier to integrate into consumer electronics, they are widely adopted in fitness trackers and lifestyle smartwatches. Their ease of use and ability to generate real-time alerts further contribute to rising demand and market expansion.

U.S. Wearable Atrial Fibrillation Detection Devices Market generated USD 265.3 million in 2024 due to widespread use of digital health technologies, higher healthcare expenditure, and growing emphasis on preventive care. As the American population ages, more individuals are turning to wearable devices for proactive cardiovascular monitoring. The presence of a strong digital health ecosystem, including partnerships between tech firms and healthcare providers, has further accelerated product adoption and innovation in the region.

Major companies shaping the Wearable Atrial Fibrillation Detection Devices Market include CardiacSense, ALIVECOR, Garmin, Google, Circular, Samsung, Withings, Apple, QARDIO, PHILIPS, iRHYTHM, ATsens, and Huawei. Companies in the wearable atrial fibrillation detection space are actively leveraging several strategies to strengthen their foothold. Product innovation remains central, with firms investing in enhancing sensor sensitivity and improving real-time ECG and PPG capabilities.

Advanced AI and machine learning models are being developed to boost detection accuracy and provide predictive analytics. Strategic partnerships with healthcare institutions help integrate wearables into remote patient monitoring systems. Companies are also focusing on miniaturization and improving user comfort to drive long-term device use. Regulatory approvals and clinical validation remain top priorities to enhance trust and market credibility.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product type
  • 2.2.3 Technology
  • 2.2.4 Distribution channel
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of atrial fibrillation
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Surge in demand for telemedicine and remote monitoring
    • 3.2.1.4 Increasing awareness about atrial fibrillation
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Complex regulatory landscape
    • 3.2.2.2 Issues related to accuracy and reliability
  • 3.2.3 Opportunities
    • 3.2.3.1 Integration with healthcare systems
    • 3.2.3.2 Emergence of AI and machine learning
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Pricing analysis
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
  • 4.2.4 Asia Pacific
  • 4.2.5 Latin America
  • 4.2.6 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Smartwatches
• 5.3 Patch monitors
• 5.4 Portable ECG monitors

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Photoplethysmography (PPG) based
• 6.3 Electrocardiogram (ECG) based

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 E-commerce
• 7.3 Brick and mortar

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 ALIVECOR
• 9.2 Apple
• 9.3 ATsens
• 9.4 CardiacSense
• 9.5 Circular
• 9.6 Garmin
• 9.7 Google
• 9.8 Huawei
• 9.9 iRHYTHM
• 9.10 PHILIPS
• 9.11 QARDIO
• 9.12 Samsung
• 9.13 Withings